Arena Faces New FDA Worries Over Weight-Loss Drug
The reviewers provided the update in a 246-page briefing document ahead of a FDA advisory committee meeting Thursday to discuss the safety and efficacy of lorcaserin, a drug to help obese patients lose weight.
Lorcaserin was earlier linked to mammary gland tumors in both sexes in a...
Already a subscriber? Click here to login